About

About Novogene Corporation Inc. Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing. About Novogene Corporation Inc. Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first-tier journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge). Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the world. Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond. With state-of-the-art laboratories and operations across the United States, the United Kingdom, Germany, China, Thailand, Korea, Singapore, and Japan, Novogene has established a strong global presence to support scientific advancements worldwide. At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis. Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life. Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first-tier journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).